It was not a particularly great time for the Enzolytics Inc (OTC: ENZC) stock this past week as it ended the week with a significant decline.
On Friday, the stock tanked by as low as 19% to end the week with total losses of 55%. In this situation, it might be worthwhile to take a closer look at Enzolytics. There was no new announcement from the company yesterday that could have led to the remarkable decline in the stock price.
As a matter of fact, in a new development not too long ago, it emerged that monoclonal antibodies that the company has been developing for targeting the coronavirus could also work on some of the different strains. The company announced that the monoclonal antibodies are also present in the South African, Brazilian, and United Kingdom strains of the coronavirus. It is a significant development for the company and investors could consider tracking these developments closely.